Trial Profile
Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary)
- Indications Retinal oedema
- Focus Adverse reactions
- 12 Apr 2017 New trial record